Ameliorative effect of rosiglitazone, a peroxisome proliferator gamma agonist on adriamycin‐induced cardio toxicity via suppressing oxidative stress and apoptosis-Reference-Cited by-同舟云学术

Ameliorative effect of rosiglitazone, a peroxisome proliferator gamma agonist on adriamycin‐induced cardio toxicity via suppressing oxidative stress and apoptosis

Published:2019-10-29 Issue:4 Volume:72 Page:607-615
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Zhang Lingling¹,Wu Ping²,Zhang Luyan³,SreeHarsha Nagaraja⁴,Mishra Anurag⁵,Su Xinyou⁶^ORCID

Affiliation:

1. Department of CardiologyBinzhou People's Hospital Binzhou China

2. Department Rear‐ServiceBinzhou People's Hospital Binzhou China

3. Department of OncologyBinzhou People's Hospital Binzhou China

4. Department of Pharmaceutical Sciences, College of Clinical PharmacyKing Faisal University Al‐Ahsa Saudi Arabia

5. School of PharmacySuresh Gyan Vihar University Jaipur India

6. Department of OncologyJinan Central Hospital Affiliated to Shandong University Jinan China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iub.2190

Reference50 articles.

1. Ameliorative Effect of Cardamom Aqueous Extract on Doxorubicin-Induced Cardiotoxicity in Rats

2. Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats

3. Cardioprotective effect of melatonin and agomelatine on doxorubicin‐induced cardiotoxicity in a rat model: An electrocardiographic, scintigraphic and biochemical study;Aygun H;Bratisl Lek Listy,2019

4. Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways

5. Aspernolide F, as a new cardioprotective butyrolactone against doxorubicin-induced cardiotoxicity

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rosiglitazone alleviates LPS-induced endometritis via suppression of TLR4-mediated NF-κB activation;PLOS ONE;2024-03-28

2. Rosiglitazone inhibits acyl‐CoA synthetase long‐chain family number 4 and improves secondary brain injury in a rat model of surgical brain injury;Clinical and Experimental Pharmacology and Physiology;2023-09-07

3. Nrf2: a dark horse in doxorubicin-induced cardiotoxicity;Cell Death Discovery;2023-07-26

4. Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis;Cell Death & Disease;2023-02-16

5. Cardiovascular protective effects of PPARγ agonists in hypothyroid rats: protection against oxidative stress;Clinical and Experimental Hypertension;2022-06-20